TLR4 and neoplasm: Conversely, the reduction of LPS trough intestinal decontamination with antibiotics, gut microbiota modulation by probiotics or genetic ablation of its receptor toll-like receptor 4 (TLR4) in mice are protective against tumor growth, representing potential targets for HCC prevention [119].